Loading...
Raltegravir in the management of HIV-infected patients
Raltegravir has recently been licensed for the treatment of HIV-1 infection. Currently its use is limited to treatment-experienced patients and subjects with resistant virus. In addition to its activity in the setting of resistance and treatment failure, it appears to have great potential for first-...
Saved in:
| Main Author: | |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove Medical Press
2009
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2761196/ https://ncbi.nlm.nih.gov/pubmed/19920914 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|